Vol. 5 — September-October 2009

• Chronic kidney disease certification process manual by the Italian Society of Nephrology (SIN): Part II: programme manag
  

  Giuseppe Quintaliani¹, Gianni Cappelli², Laura Lodetti³, Corrado Manno⁴, Virgilio Petrucci⁵, Cosimo Spinelli⁶, Renzo Tarchini⁷, Michele Virgilio⁸, Mario Faini⁹, Sandro Alloatti¹⁰, Giovanni Cancarini¹¹, Carmine Zoccali¹²

  (1) Nephrology and Dialysis Unit, Perugia Hospital,Perugia, Italy
  (2) Nephrology and Dialysis Unit, University Policlinic ofModena, Italy
  (3) PROGEA, Milan, Italy
  (4) Nephrology and Dialysis Unit, University Policlinic of Bari,Bari, Italy
  (5) Nephrology and Dialysis Unit, Ascoli Piceno Hospital,Ascoli Piceno, Italy
  (6) Nephrology and Dialysis Unit, Nephrology and DialysisUnit, S. Spirito Hospital, Rome, Italy
  (7) Nephrology and Dialysis Unit, Mantova Hospital,Mantova, Italy
  (8) Nephrology and Dialysis Unit, Molfetta Hospital,Molfetta, Italy
  (9) PROGEA, Milan, Italy
  (10) Nephrology and Dialysis Unit, Aosta Hospital,Aosta, Italy
  (11) Nephrology and Dialysis Unit, University Policlinic ofBrescia, Brescia, Italy
  (12) Nephrology and Dialysis Unit, Reggio Calabria Hospital,Reggio Calabria, Italy

• Chronic kidney disease among Indigenous populations: considerations for effective and ethical research
  

  Carrie D. Kolewaski, Karen Yeates¹

  (1) Department of Medicine, Queen’s University, Kingston,Ontario, Canada

• Hypertension in the elderly: new and old evidence that treatment may benefit the old
  

  Robert H. Fagard¹

  (1) Hypertension and Cardiovascular Rehabilitation Unit, Faculty of Medicine, University of Leuven, Leuven, Belgium

• Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
  

  Charles Chazot¹

  (1) Centre de Rein Artificiel, Tassin, France

• Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence
  

  Mehmet Kanbay¹, Faruk Turgut¹, Adrian Covic, David Goldsmith²

  (1) Department of Internal Medicine, Section of Nephrology, Fatih University School of Medicine, Ankara, Turkey
  (2) Department of Internal Medicine, Renal Unit, Guy’s Hospital, London, UK

• Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome
  

  Norishi Ueda¹, Kazuhiro Takahashi², Yuko Akioka³, Masafumi Morooka³, Akimasa Ogawa⁴, Kazuo Tsuzuki⁵

  (1) Department of Developmental Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
  (2) Department of Pediatric Nephrology, Chiba Children’s Hospital, Chiba, Chiba, Japan
  (3) Department of Pediatrics, Fujita Health University Graduate School of Medicine, Toyoake, Aichi, Japan
  (4) Depatrment of Pediatrics, Anjo Kosei Hospital, Anjo, Aichi, Japan
  (5) Department of Pediatrics, Chukyo Hospital, Nagoya, Aichi, Japan

• Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients
  

  Giorgio Coen¹, Daniela Mantella¹, Daniela Sardella¹, Maria Pia Beraldi², Irene Ferrari, Andrea Pierantozzi¹, Basilio Lippi¹, Salvatore Di Giulio

  (1) Ospedale Israelitico, Rome, Italy
  (2) Department of Nephrology, Hospital of Forlanini, San Camillo, Rome, Italy

• Dimethylarginine levels and nutritional status in hemodialysis patients
  

  Adamasco Cupisti¹, Alessandro Saba², Claudia D’Alessandro¹, Mario Meola¹, Erica Panicucci³, Vincenzo Panichi¹, Andrea Raffaelli⁴, Giuliano Barsotti¹

  (1) Nephrology Section, Department of Internal Medicine, University of Pisa, Pisa, Italy
  (2) Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy
  (3) Department of Experimental Pathology, University of Pisa, Pisa, Italy
  (4) Institute of Chemistry of Organometallic Compounds, National Research Council, Pisa, Italy

• Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane flui
  

  Giancarlo Goi¹, Luca Massaccesi¹, Claudia J. Baquero Herrera¹, Claudio Musetti², Daniele Ciurlino³, Daniele Cusi⁴, Silvio Bertoli³

  (1) Department of Medical Chemistry, Biochemistry and Biotechnology, University of Milan, Milan, Italy
  (2) Dialysis Unit, IRCCS Multimedica, Sesto San Giovanni, Milan, Italy and Graduate School of Nephrology, University of Milan, Milan, Italy
  (3) Dialysis Unit, IRCCS Multimedica, Sesto San Giovanni, Milan, Italy
  (4) Graduate School of Nephrology, University of Milan,Milan, Italy and Division of Nephrology, San Carlo Borromeo Hospital, Milan, Italy

• Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients
  

  Ary Serpa Neto¹, Felipe Martin Bianco Rossi¹, Rodrigo Dal Moro Amarante², Nara Alves Buriti¹, Gabriel Cunha Barbosa Saheb¹, Marçal Rossi

  (1) Division of Clinical and Surgical Treatment of Obesity, ABC Medicine School, São Paulo, Brazil
  (2) Division of Clinical and Surgical Treatment of Obesity, ABC Medicine School, São Paulo,Brazil

• Alkalinization potentiates vascular calcium deposition in an uremic milieu
  

  Alain J. de Solis¹, Francisco R. Gonzalez-Pacheco², Juan J.P. Deudero², Fernando Neria³, Marta Albalate⁴, Vladimir Petkov⁴, Luis Susanibar⁴, Ruth Fernandez-Sanchez², Olalla Calabia², Alberto Ortiz⁴, Carlos Caramelo⁵

  (1) Laboratory of Nephrology and Hypertension,Jiménez Díaz-Capio Fundation, Universidad Autónoma de Madrid, Queen Sophie Renal Research Institute, Madrid - Spain
  (2) Jiménez Díaz-Capio Fundation, Universidad Autónoma de Madrid, Queen Sophie Renal Research Institute, Madrid - Spain
  (3) Laboratory of Nephrology and Hypertension,Jiménez Díaz-Capio Fundation, Universidad Autónoma de Madrid, Queen Sophie Renal Research Institute, Madrid, Spain
  (4) Dialysis Unit, Jiménez Díaz-Capio Fundation,Universidad Autónoma de Madrid, Queen Sophie RenalResearch Institute, Madrid - Spain
  (5) Laboratory of Nephrology and Hypertension,Jiménez Díaz-Capio Fundation, UniversidadAutónoma de Madrid, Queen Sophie Renal ResearchInstitute, Madrid, Spain and Dialysis Unit, Jiménez Díaz-Capio Fundation, Universidad Autónoma de Madrid, Queen Sophie Renal Research Institute, Madrid, Spain

• Management of chronic kidney disease in Taiwan: room for quality improvement
  

  Hsin-Wei Kuo¹, Shang-Shyue Tsai², Mao-Meng Tiao³, Yi-Chun Liu¹, Chun-Yuh Yang⁴

  (1) Division of Nephrology, Department of Internal Medicine, Yuan’s General Hospital, Kaohsiung, Taiwan
  (2) Department of Healthcare Administration, I-Shou University, Kaohsiung County, Taiwan
  (3) Department of Pediatrics, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan
  (4) Institute of Public Health, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan

• Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA re
  

  Francesco Locatelli¹, Adrian Covic², Iain C. Macdougall³, Armin Scherhag, Andrzej Wiecek⁴, on behalf of the ORAMA Study Group

  (1) Department of Nephrology, Dialysis and Renal Transplantation, A. Manzoni Hospital, Lecco, Italy
  (2) C. I. Parhon Hospital and University of Medicine, Gr. T. Popa, Iasi, Romania
  (3) Renal Unit, King’s College Hospital, London, UK
  (4) Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland

• Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia
  

  Christian Ott¹, Martin Ritt², Stephanie I. Titze², Tim Schäufele³, Roland E. Schmieder⁴

  (1) Department of Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen , Germany
  (2) Department of Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen, Germany
  (3) Heart Institute, Lahr, Germany
  (4) Department of Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen, Germany

• Hemizygous Fabry disease associated with IgA nephropathy: a case report
  

  Homare Shimohata¹, Keigyou Yoh², Kenji Takada³, Hiroaki Tanaka³, Joichi Usui², Kouichi Hirayama¹, Masaki Kobayashi¹, Kunihiro Yamagata²

  (1) Department of Nephrology, Tokyo Medical University, Ibaraki Medical Center, Ibaraki, Japan
  (2) Pathophysiology of Renal Diseases, Doctoral Programin Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan
  (3) Tsukuba Gakuen Hospital, Ibaraki, Japan